Oxygen Therapy for Alzheimer's Disease: Not a Cure

Oxygen therapy does not cure Alzheimer's disease (AD). AD is a progressive neurodegenerative disorder characterized by amyloid-β plaques, tau tangles, synaptic loss, and neuronal death.

Why Oxygen Therapy Isn't a Cure

• Pathology is not hypoxia: AD neurodegeneration is driven by protein misfolding, neuroinflammation, and metabolic dysfunction—not primarily by low oxygen.
• No disease-modifying effect: Supplemental O₂ does not reduce amyloid, tau, or reverse atrophy.
• Evidence: No RCT shows cognitive improvement or disease slowing with chronic O₂ in AD. Hyperbaric oxygen (HBOT) studies are small, inconclusive.

When Oxygen Is Used in Dementia Patients

• Coexisting COPD, heart failure, pneumonia → hypoxemia correction.
• Acute hypoxia from any cause.
• Palliative comfort (dyspnea relief).

Actual AD Treatments

• Cholinesterase inhibitors: Donepezil, rivastigmine, galantamine (mild-moderate).
• NMDA antagonist: Memantine (moderate-severe).
• Anti-amyloid mAbs: Lecanemab, donanemab (early symptomatic, amyloid-positive; modest slowing, ARIA risk).
• Non-pharmacologic: Cognitive stimulation, exercise, Mediterranean diet, social engagement, vascular risk control.

Hope vs. Hype

Oxygen may help comorbid conditions but does not treat AD pathology. Focus on evidence-based therapies and quality-of-life support.